Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

9.060 -0.080 (-0.88%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
What 9 Analyst Ratings Have To Say About Prothena Corp ↗
Analysts have provided the following ratings for Prothena Corp (NASDAQ:PRTA 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Monday ↗
Jefferies raised the price target on Tesla, Inc. (NASDAQ: 
Via Benzinga
News headline image
Recap: Prothena Corp Q2 Earnings ↗
Shares of Prothena Corp (NASDAQ:PRTA) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 187.88% year over year to $0... 
Via Benzinga
News headline image
Why Is Novo Nordisk Buying a Rare-Disease Candidate? ↗
The company is mainly known for its diabetes drugs but has some background in rare-disease drugs. 
Via The Motley Fool
Where Prothena Corp Stands With Analysts ↗
Within the last quarter, Prothena Corp (NASDAQ:PRTA) has ... 
Via Benzinga
Where Prothena Corp Stands With Analysts ↗
Prothena Corp (NASDAQ:PRTA) has observed the following an... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Tuesday ↗
Wells Fargo lowered C.H. Robinson Worldwide, Inc. (NASDAQ: 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Surges Over 100 Points; State Auto Financial Shares Jump ↗
Toward the end of trading Monday, the Dow traded up 0.34% to 34,987.02 while the NASDAQ rose 0.08% to 14,713.30. The S&P also rose, gaining 0.26% to 4,380.72. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
Mid-Day Market Update: Crude Oil Down 1%; Celldex Therapeutics Shares Spike Higher ↗
Midway through trading Monday, the Dow traded up 0.28% to 34,967.12 while the NASDAQ rose 0.08% to 14,714.09. The S&P also rose, gaining 0.23% to 4,379.69. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
Mid-Morning Market Update: Markets Mostly Higher; Novo Nordisk To Acquire Prothena's ATTR Amyloidosis Program ↗
Following the market opening Monday, the Dow traded up 0.32% to 34,981.25 while the NASDAQ fell 0.07% to 14,691.53. The S&P also rose, gaining 0.15% to 4,376.17. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Novo Nordisk To Buy Prothena's ATTR Amyloidosis Program For Up To $1.2B ↗
Novo Nordisk A/S (NYSE: NVO) will acquire Prothena Corporation plc's (NASDAQ: PRTA) and clinical stage antibody PRX004 and broader ATTR amyloidosis... 
Via Benzinga
News headline image
64 Biggest Movers From Friday ↗
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares surged 597.8% to settle at $34.89 on Friday as the company priced its IPO at $5 per share. SGOCO Group, Ltd. (NASDAQ: SGOC)... 
Via Benzinga
Topics Initial Public Offering
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Galectin Therapeutics (NASDAQ:GALT) shares moved upwards by 35.0% to $3.73 during Friday's regular session. As of 12:30 EST, Galectin Therapeutics's stock... 
Via Benzinga
News headline image
40 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Stamps.com Inc. (NASDAQ: STMP) jumped 63.7% to $323.63. Software investment firm Thoma Bravo inked an agreement to acquire e-commerce shipping solutions provider Stamps.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 18, 2021 ↗
Upgrades According to JP Morgan, the prior rating for Orion Engineered Carbons SA (NYSE: 
Via Benzinga
News headline image
Return On Capital Employed Overview: Prothena Corp ↗
In Q1, Prothena Corp (NASDAQ:PRTA) posted sales of $160.00 thousand. Earnings were up 5.94%, but Prothena Corp still reported an overall loss of $32.11 million. Prothena Corp... 
Via Benzinga
News headline image
50 Biggest Movers From Yesterday ↗
Gainers Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share. Midatech Pharma plc (NASDAQ... 
Via Benzinga
Topics Initial Public Offering
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers Midatech Pharma (NASDAQ:MTP) stock rose 36.76% to $2.79 during Thursday's regular session. Midatech Pharma's stock is trading at a volume of 69.8 million... 
Via Benzinga
News headline image
34 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 68.5% to $5.51 after the company announced it filed a registration statement in connect with the proposed merger... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Satsuma Pharmaceuticals (NASDAQ:STSA 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Tuesday ↗
Before 10 a.m. ET on Tuesday, 125 stocks hit new 52-week highs. Significant Points: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Monday ↗
During Monday's morning session, 255 companies made new 52-week highs. Points of Interest: The largest company by market cap to set a new 52-week high was Adobe (... 
Via Benzinga
News headline image
Biotechs Ready To Roar ↗
The biggest event last week was the FDA decision to approve Biogen's drug aducanumab, a treatment for Alzheimer's disease. The decision will reverberate across the industry and the healthcare sector... 
Via Talk Markets
News headline image
10 Biggest Price Target Changes For Friday ↗
Barclays lowered Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) price target from $302 to $285. Vertex Pharmaceuticals shares fell 13.3% to $187.88 in pre-market trading.... 
Via Benzinga
News headline image
Why Biogen, Lilly, and Prothena Stocks Soared This Week ↗
The FDA's approval of Biogen's Aduhelm in treating Alzheimer's disease boosted all three stocks. 
Via The Motley Fool
News headline image
10 Biggest Price Target Changes For Thursday ↗
Telsey Advisory Group lifted RH (NYSE: RH) price target from $675 to $725. RH shares rose 8.3% to $662.00 in pre-market trading. Keybanc raised the price target on Oxford... 
Via Benzinga
News headline image
66 Biggest Movers From Yesterday ↗
Gainers Orphazyme A/S (NASDAQ: ORPH) shares jumped 302.3% to close at $21.00 on Thursday. Shares of the biopharmaceutical firm touched an intraday high of $77.77, running up 1,... 
Via Benzinga
News headline image
Biogen Snagged: Will Hefty Price Tag Hinder Alzheimer's Drug Use? ↗
Biogen stock dipped Tuesday as analysts questioned how much use its potential blockbuster Alzheimer's treatment, Aduhelm, would ultimately secure. 
Via Investor's Business Daily
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares surged 87.3% to close at $9.14 on Monday on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) gained 60.3% to settle... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Atossa Therapeutics (NASDAQ:ATOS)... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.